Targeting DR5 remains a promising approach to help induce cell death by apoptosis or necroptosis (in combination with agents such as the SMAC mimetic birinapant) in the cancer cells of difficult-to-treat malignancies such as sarcoma. The gene discussed is TNFRSF10B; the disease is cancer.